SPIE Belgium joins consortium to build PanTera cancer isotope facility in Mol

  • SPIE Belgium, subsidiary of SPIE SA, joined consortium with Willemen, Cordeel, Imtech to build PanTera actinium-225 production facility in Mol, Belgium, supporting targeted cancer treatments.
  • Scope covers critical building systems including HVAC, plumbing, technical gas installations for site designed by Modulo, with Tractebel as project agency.
  • Construction of underground structure started; SPIE Belgium set to begin installation work in late 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SPIE SA published the original content used to generate this news brief on May 07, 2026, and is solely responsible for the information contained therein.